Detection of early central circulatory transits in patients with cirrhosis by gamma variate fit of indicator dilution profiles

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 4 51-4, 2005, Pages

  Henriksen, Jens H ^a,b   Møller, Søren ^a   Fuglsang, Stefan ^a   Bendtsen, Flemming ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Central blood volume; Exponential fit; Indicator dilution technique; Kinetic principles; Pulmonary shunts; Ventilation perfusion ratio

Indexed keywords

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD VOLUME; CENTRAL VENOUS CATHETERIZATION; CIRCULATION TIME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA VARIATE FIT; HEART OUTPUT; HUMAN; INDICATOR DILUTION CURVE; LIVER CIRCULATION; LIVER CIRRHOSIS; LUNG ARTERIOVENOUS SHUNT; LUNG VENTILATION PERFUSION RATIO; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SWAN GANZ CATHETER;

ADULT; AGED; ARTERIES; BLOOD CIRCULATION; BLOOD VOLUME; CARDIAC OUTPUT; CASE-CONTROL STUDIES; FEMALE; GASES; HEMODYNAMIC PROCESSES; HUMANS; INDICATOR DILUTION TECHNIQUES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 15244359671     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00201.2004     Document Type: Article

References (39)

1. Albrecht T, Blomley MJK, Cosgrove DO, Taylor-Robinson S, Jayaram V, Eckersley R, Urbank A, Butler-Barnes J, and Patel N. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 353: 1579-1583, 1999.
2. Aller R, Moya JL, Moreira V, Garcia-Lledo A, Sanroman AL, Paino C, and Boixeda D. Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography. J Hepatol 31: 1044-1052, 1999.
3. Blomley MJK, Cooke JC, Unger E, Monraghan J, and Cosgrove D. Microbubble contrast agents: a new era in ultrasound. Br Med J 322: 1222-1225, 2001.
4. Blomley MJK, Lim AKP, Harvej CJ, Patel N, Eckersley RJ, Basilico R, Heckemann R, Urbank A, Cosgrove DO, and Taylor-Robinson SD. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut 52: 1188-1193, 2003.
5. Colombato LA, Albillos A, and Groszmann RJ. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 110: 193-198, 1996.
6. Fallon MB and Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 32: 859-865, 2000.
7. Fernández-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martin P, Arroyo V, Solé M, Rivera F, Rodés J, and Jimenéz W. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. Am J Pathol 162: 1985-1993, 2003.
8. Garrett JS, Lanzer P, Jaschke W, Botvinick E, Sievers R, Higgins CB, and Lipton MJ. Measurement of cardiac output by cine computed tomography. Am J Cardiol 56: 657-661, 1985.
9. Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, and La Villa G. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 30: 632-638, 1999.
10. Ghttoni G, Valentini G, Spada C, Rossi Z, and Gasbarrini G. Hepatopulmonary syndrome. A review of the literature. Panminerva Med 45: 95-98, 2003.
11. Gluud C. Serum testosterone concentration in men with alcoholic cirrhosis: background for variation. Metabolism 36: 373-378, 1987.
12. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In: Portal Hypertension. Pathophysiology and Treatment, edited by Bosch J and Groszmann RJ. Oxford, UK: Blackwell, 1994, p. 17-26.
13. Hamilton WF, Riley RL, Attyah AM, Cournand A, Fowell DM, Himmelstein A, Noble RP, Remington JW, Richards DW Jr, Wheeler NC, and Witham AC. Comparison of the Fick and dye injection methods of measuring the cardiac output in man. Am J Physiol 153: 309-321, 1948.
14. Harpen MD and Lecklitner ML. Derivation of gamma variate indicator dilution function from simple convective dispersion model of blood flow. Med Phys 11: 690-692, 1984.
15. Henriksen JH, Bendtsen F, Christensen NJ, Gerbes AL, Ring-Larsen H, and Sørensen TIA. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, β-adrenergic blockade, and atrial natriuretic factor. Hepatology 16: 1163-1170, 1992.
16. Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, and Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 97: 1506-1513, 1989.
17. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, and Møller S. Arterial compliance in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol 280: G584-G594, 2001.
18. Henriksen JH, Ring-Larsen H, Kanstrup IL, and Christensen NJ. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with cirrhosis. Gut 25: 1034-1043, 1984.
19. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, and Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 11: 1153-1166, 1998.
20. Hosono M, Machida K, Honda N, Takahashi T, Kashimada A, Osada H, Murata O, Ohtawa N, and Nishimura K. Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis. Ann Nucl Med 16: 577-581, 2002.
21. Kelbæk H, Hartling OJ, Skagen K, Munck O, Henriksen O, and Godtfredsen J. First-pass radionuclide determination of cardiac output: an improved gamma camera method. J Nucl Med 28: 1330-1334, 1987.
22. Kiszka-Kanowitz M, Henriksen JH, Møller S, and Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 35; 605-612, 2001.
23. Kuikka JT. Effect of increasing blood flow on distribution of pulmonary transit times in man. Physiol Meas 21: 241-250, 2000.
24. Lassen NA, Henriksen JH, and Sejrsen P. Indicator method for measurement of organ and tissue blood flow. In: Handbook of Physiology: The Cardiovascular System. Perhipheral Circulation and Organ Blood Flow. Bethesda, MD: Am. Physiol. Soc., 1984, sect. 2, vol. III, pt. 1, chapt. 2, p. 21-63.
25. Lassen NA and Perl W. Tracer kinetic methods in medical physiology. New York: Raven, 1979, p. 1-189.
26. Lieberman FL, Denison EK, and Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: The overflow theory of ascites formation. Ann NY Acad Sci 170: 202-212, 1970.
27. Madsen MT. A simplified formulation of the gamma variate function. Phys Med Biol 32: 1597-1600, 1997.
28. Møller S, Bendtsen F, Christensen E, and Henriksen JH. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol 21: 940-946, 1994.
29. Møller S, Bendtsen F, and Henriksen JH. Effects of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 109: 1917-1925, 1995.
30. Møller S, Henriksen JH, and Bendtsen F. Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 284: G970-G979, 2003.
31. Møller S, Hillingsø J, Christensen E, and Henriksen JH. Arterial hypoxaemia in cirrhosis: fact or fiction? Gut 42: 868-874, 1998.
32. Morali GA and Blendis LM. What does "reduced central blood volume in cirrhosis" really mean? Hepatology 13: 1261, 1991.
33. Press WH, Flannery BP, Teukolsky SA, and Vetterling WT. Numerical recipes in C. Cambridge, UK: Cambridge University Press, 1990.
34. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, and Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 135: 1085-1092, 1987.
35. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, and Muller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 51: 853-859, 2002.
36. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, and Rodés J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 5: 1151-1157, 1988.
37. Schwab AJ and Pang KS. The multiple indicator dilution method and its utility in risk assessment. Environ Health Perspect 108, Suppl 5: 861-872, 2000.
38. Soderman C, Juhlin-Dannfelt A, Lagerstrand L, and Eriksson LS. Ventilation-perfusion relationships and central haemodynamics in patients with cirrhosis. Effects of a somatostatin analogue. J Hepatol 21: 52-57, 1994.
39. Thomson HK, Starmer F, Whalen RE, and McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res 14: 502-514, 1964.